Seeking Alpha

Forbes' Matthew Herper notes that the CEO of Fougera, which Novartis is buying for $1.525B, is...

Forbes' Matthew Herper notes that the CEO of Fougera, which Novartis is buying for $1.525B, is Brian Markison, who was CEO of King Pharmaceuticals when it was sold to Pfizer for $3.6B in 2010. Herper speculates that Markison won't be short of job offers, especially if there are any other drug firms looking to get bought.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|